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The purpose of this study was to determine prevalence and molecular characteri-
zation of plasmid-mediated quinolone resistance (PMQR) genes [qnrA, qnrB, qnrC,
qnrD, qnrS, aac(6′)-Ib-cr, qepA, and oqxAB] among extended-spectrum beta-lactamase
(ESBL)-producing Escherichia coli and Klebsiella spp. isolates from bloodcultures in
Hungary. A total of 103 isolates were tested for quinolone susceptibility by microdilution
method and PMQR genes were detected by polymerase chain reaction. About 40 ESBL-
producing E. coli (39%) and 50 ESBL-producing Klebsiella spp. strains (48%) were
resistant to ciproﬂoxacin; 40 ESBL-producing E. coli (39%) and 47 ESBL-producing
Klebsiella spp. strains (45%) were resistant to levoﬂoxacin; and 88 strains including 40
ESBL-producing E. coli (39%) and 48 (47%) ESBL-producing Klebsiella spp. were
resistant to moxiﬂoxacin. Among the 103 ESBL-producing isolates, 77 (75%) isolates (30
E. coli and 47Klebsiella spp.) harbored PMQR genes. The most commonly detected gene
was aac(6′)-Ib-cr (65%). The occurrence of qnrS gene was 6%. Interestingly, qnrA, qnrB,
qnrC, qnrD, and qepAwere not found in any isolates. Among 77 PMQR-positive isolates,
27 (35.1%) and 1 (1.3%) carried two and three different PMQR genes, respectively. Only
Klebsiella spp. harbored more than one PMQR genes. Observing prevalence of PMQR
genes in the last 8 years, the increasing incidence of aac(6′)-Ib-cr and oqxAB can be
seen. Our results highlight high frequency of PMQR genes among ESBL-producing
Klebsiella pneumoniae and E. coli isolates with an increasing dynamics in Hungary.
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Introduction
Fluoroquinolones (FQs) possess an excellent activity against gram-negative
bacteria especially against Enterobacteriaceae and have been extensively used for
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treatment of infections caused by these pathogens since their introduction in the
1980s [1]. The mode of action of FQs is the inhibition of type II DNA topoisome-
rases, namely, gyrase and topoisomearse IV [2]. DNA gyrase is the primary target for
quinolones in gram-negative bacteria due to higher sensitivity of that enzyme to
quinolone inhibition and formation of drug–enzyme–DNA complexes in comparison
to the sensitivity of other topoisomerases. Resistance to FQs was explained by
accumulation of mutations in the chromosomal genes, encoding DNA gyrase and
topoisomerase IV bacterial enzymes, namely, gyrA, gyrB, parC, and parE. Further
resistance mechanisms are the decreased intracellular drug accumulation by upre-
gulation of native chromosomally encoded efﬂux pump AcrAB or decreased
expression of outer membrane porins, e.g., OmpF in Escherichia coli [1, 3–5].
Plasmid-mediated quinolone resistance (PMQR) determinants – qnr deter-
minants (qnrA, qnr, BqnrS, qnrC, and qnrD), aminoglycoside acetyltransferase
(6′)-Ib-cr variant, and speciﬁc efﬂux pumps, namely, QepA and OqxAB – were
discovered as new ways of FQ resistance, mainly in Enterobacteriaceae. The
acquisition of qnr genes leads to low-level FQ resistance, which is meant to be
higher minimal inhibitory concentration (MIC) values than the wild-type but still
below the internationally approved resistance breakpoints by European Commit-
tee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Labo-
ratory Standards Institute. In the status of low-level resistance, bacterial strains
have 100 times increased mutation frequency (from 108 to 106) on chromosomal
gene (e.g., gyr), which facilitates the selection to high-level FQ resistance [6–9].
PMQR genes are frequently associated with various beta-lactamase genes,
including extended-spectrum beta-lactamases (ESBLs) and narrow spectrum-
beta-lactamases, as these resistance determinants are located on same plasmids.
Resistance plasmids are usually transferable by conjugation that facilitates their
dissemination between different Enterobacteriaceae species [9, 10].
In this study, our aim was to determine the PMQR determinants among
ESBL-producing Enterobactericeae strains from bloodcultures.
Materials and Methods
Bacterial strains
In this study, 103 ESBL-producing Enterobacteriaceae isolates from
bloodstream infections (49 E. coli and 54 Klebsiella spp.) of patients treated at
intensive care units of Semmelweis University between 2010 and 2014 were
collected. Species identiﬁcation was done by MALDI-TOF/MS (Bruker Daltonik
GmbH, Bremen, Germany).
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Antibiotic susceptibility
MIC values of nalidixic acid, ciproﬂoxacin, levoﬂoxacin, and moxiﬂoxacin
were determined by broth microdilution methods using EUCAST criteria on all
103 isolates [6]. E. coli ATCC 25922 and Klebsiella pneumoniae ATCC 700603
were reference strains for antimicrobial susceptibility testing.
Phenotypic detection of ESBL production
Double-disk synergy tests were performed by placing disks of ceftazidime,
cefotaxime, and cefepime at a distance of 20 and 30 mm (center to center) from
a disk containing amoxicillin plus clavulanic acid (20/10 μg). A “keyhole”
phenomenon was regarded as positive for ESBL production.
Detection of PMQR genes by PCR
Detection of genes encoding PMQR – qnrA, qnrB, qnrC, qnrD, qnrS, aac
(6’)- Ib-cr, qepA and oqxAB – was performed on all isolates. A single colony of
each test isolate was resuspended in 400-μl double distilled water and was boiled
at 100 °C for 15 min. A supernatant was obtained after centrifugation at 13,000 rpm
for 15 min and was used as bacterial DNA template in polymerase chain reaction
(PCR) assays. The primers for detection of qnrA, qnrB, qnrC, qnrD, qnrS, aac(6′)-
Ib-cr, qepA, and oqxAB genes are shown in Table I. PCRs were performed with
RedTaq DNA polymerase (Sigma-Aldrich, St. Louis, MO, USA), according to
manufacturer’s instructions with 2 μl of DNA template in a total reaction volume
of 30 μl. DNA ampliﬁcation programs consisted of an initial denaturation step
(96 °C for 5 min) followed by 30 cycles of denaturation (96 °C for 30 s), annealing
for 30 s (annealing temperature for each primer set is shown in Table I), and
extension (72 °C for 1 min), and a ﬁnal extension of 5 min at 72 °C. Ten
microliters of reaction mixture containing PCR product was analyzed by gelelec-
trophoresis in 0.8% (wt/vol) agarose gel (Sigma-Aldrich) with 120 V for 30 min in
electrophoresis system (Bio-Rad, Hercules, CA, USA).
Results
Antibiotic susceptibility
About 40 ESBL-producing E. coli (39%) and 50 ESBL-producing Klebsi-
ella spp. strains (48%) were resistant to ciproﬂoxacin; 40 ESBL-producing E. coli
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(39%) and 47 ESBL-producing Klebsiella spp. strains (45%) were resistant to
levoﬂoxacin; and 88 strains including 40 ESBL-producing E. coli (39%) and 48
(47%) ESBL-producing Klebsiella spp. were resistant to moxiﬂoxacin. The
distribution of MIC values of ESBL-producing E. coli and Klebsiella spp. is
shown in Figures 1 and 2.
Detection of PMQR genes
Among 103 ESBL-producing isolates, 77 (75%) harbored PMQR genes,
and 30 E. coli and 47 Klebsiella spp. were detected. The most commonly detected
gene was aac(6′)-Ib-cr (65%). The occurrence of qnrS gene was 6%. Interestingly,
qnrA, qnrB, qnrC, qnrD, and qepA were not found in any isolates.
Among 49 ESBL-producing E. coli strains, 29 harbored aac(6′)-Ib-cr gene
and one carried qnrS. In 19 isolates, PMQR genes were not detected.
Among 53 K. pneumoniae, 38 harbored aac(6′)-Ib-cr gene and ﬁve isolates
carried qnrS. 26 K. pneumoniae isolates were positive for oqxA and 22 for oqxB
genes.
Only six isolates – one E. coli, four K. pneumoniae, and one K. oxytoca
isolates – harbored qnrS. The characteristics of these strains are summarized
Table I. Primers used in this study





qnrA-F ATTTCTCACGCCAGGATTTG 516 53 [11]
qnrA-R GATCGGCAAAGGTTAGGTCA
qnrB-F ATGACGCCATTACTGTATAA 469 53 [12]
qnrB-R GATCGCAATGTGTGAAGTTT
qnrS-F ACG ACA TTC GTC AAC TGC AA 417 53 [11]
qnrS-R TAA ATT GGC ACC CTG TAG GC
qnrC-F GGGTTGTACATTTATTGAATC 447 50 [13]
qnrC-R TCCACTTTACGAGGTTCT
qnrD-F CGAGATCAATTTACGGGGAATA 582 50 [14]
qnrD-R AACAAGCTGAAGCGCCTG
aac(6’)Ib-cr-F TTGCGATGCTCTATGAGTGGCTA 482 54 [15]
aac(6’)Ib-cr-R CTCGAATGCCTGGCGTGTTT
oqxA-F CTCGGCGCGATGATGCT 392 57 [16]
oqxA-R CCACTCTTCACGGGAGACGA
oqxB-F TTCTCCCCCGGCGGGAAGTAC 512 64
oqxB-R CTCGGCCATTTTGGCGCGTA
qepA-F GCA GGT CCA GCA GCG GGT AG 199 60 [17]
qepA-R CTT CCT GCC CGA GTA TCG TG
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in Table II. Interestingly, the strain harboring qnrS did not contain other
PMQR genes.
Among 77 PMQR-positive isolates, 27 (35.1%) and 1 (1.3%) carried two
and three different PMQR genes, respectively. Only Klebsiella spp. harbored more
than one gene. The distribution and coexistence of PMQR genes among the 103
ESBL-producing isolates are shown in Tables III and IV: The distribution of
Figure 1. The MIC values (mg/L) of ESBL-producing E. coli isolates
Figure 2. The MIC (mg/L) values of ESBL-producing Klebsiella spp.
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ciproﬂoxacin MIC (mg/L) values of Klebsiella spp. harboring no or one or two
PMQR genes parallel is shown in Figure 3. There is no correlation between
ciproﬂoxacin MIC values and number of the harbored PMQR genes, as cipro-
ﬂoxacin MIC values of these strains ranged between 0.25 and 128 mg/L.
Table II. Characteristics of qnrS harboring strain
MIC (mg/L)
Strain Ciproﬂoxacin Levoﬂoxacin Moxiﬂoxacin PMQR genes
E. coli 58 >128 >128 >128 qnrS
K. pneumoniae 33 >128 >128 >128 qnrS, oqxA, oqxB
K. pneumoniae 47 128 32 128 qnrS
K. pneumoniae 115 128 8 8 qnrS
K. pneumoniae 125 128 64 64 qnrS
K. oxytoca 37 <0.25 <0.25 1 qnrS
Table III. Distribution of PMQR genes among 103 ESBL producers
Resistance genes
Number (%) of all
ESBL producers
Number (%) of ESBL-producing
Klebsiella spp.
aac(6’)-Ib-cr 67 (65%) 38 (70%)
qnrA 0 (0%) 0 (0%)
qnrB 0 (0%) 0 (0%)
qnrC 0 (0%) 0 (0%)
qnrD 0 (0%) 0 (0%)
qnrS 6 (5.8%) 5 (9%)
qepA 0 (0%) 0 (0%)
oqxA 26 (25.2%) 26 (48%)
oqxB 22 (21.4%) 22 (40%)
Table IV. Coexisting PMQR resistance genes among 103 ESBL producers
Coexisting resistance genes
Number (%) of all
ESBL producers
Number (%) of ESBL-producing
Klebsiella spp.
aac(6’)-Ib-cr, oqxA and oqxB 13 (12.6%) 13 (24%)
qnrS, oqxA and oqxB 1 (0.97%) 1 (1.8%)
oqxA and oqxB 7 (6.8%) 7 (13%)
aac(6’)-Ib and qnrS 2 (1.9%) 2 (3.8%)
aac(6’)-Ib and oqxA 3 (2.9%) 3 (5.7%)
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Conclusions
This study demonstrated that the most prevalent PMQR gene was aac
(6′)-Ib-cr (68.8%) followed by oqxA (48%), oqxB (40%), and qnrS (6.4%).
Comparing these data to earlier report from Hungary, Szabo´ et al. [18] showed
nearly the same frequency in qnr resistance genes among ESBL-producing
strains 3% in ESBL-producing K. pneumoniae and 1.4% in ESBL-producing
E. coli isolates. By contrast, qnrA gene was not detected in this study, only
qnrS was observed among bloodculture isolates. On the other hand, qnrA has
same frequency among urinary tract isolates (unpublished data, personal
communication with Dr. Kocsis) compared to earlier published Hungarian
data [18]. Frequency of qnr genes in K. pneumoniae isolates varies in
different countries: in China, 65.5% [19]; Malaysia, 48.9% [20] USA,
11.1% [21]; Singapore, 5.2% [22]; Italy, 5.02% [23]; and Brazil, 2.3%
[24]. In this study, among E. coli and Klebsiella spp., no qnrD was detected.
This is not surprising, as other studies found this resistance determinant
mainly in Proteeae tribe (Proteus spp., Morganella spp., and Providencia
spp.) of Enterobacteriaceae [25, 26].
Interestingly, in this work, the prevalence of aac(6′)-Ib-cr increased dra-
matically from 26.6% to 68.8%, since the ﬁrst detection in Hungary [18]. Different
frequency of aac(6′)-Ib-cr among ESBL producers has been reported in several
countries, namely, 70.1% in Iran [27] and 16.2% in Spain [28].
OqxAB, as a multidrug efﬂux pump, confers resistance to quinolone,
such as ciproﬂoxacin, ﬂumequine, norﬂoxacin, and nalidixic acid, and other
antibiotics, such as chloramphenicol and trimethoprim [29]. This study
Figure 3. The distribution of ciproﬂoxacin MIC (mg/L) values of Klebsiella spp. harboring no or
one or two PMQR genes
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demonstrated that among ESBL-producing K. pneumoniae, a prevalence of
48% and 40% for oqxA and oqxB genes, respectively, can be seen. Different
countries reported various prevalence data: 76.3% for oqxA and 74.6% for
oqxB in Spain [30] and 100% for both genes in China [31]. As in other
studies, qepA was not present in our ESBL-producing clinical isolates
[27, 32].
In this study, there was no correlation between quinolone MIC values
and harbored PMQR determinants, as four PMQR harboring strains exhibited
susceptible ciproﬂoxacin MICs, while 45 PMQR-positive strains were resistant
to FQs.
In summary, our results of this study reﬂected considerable frequency of aac
(6′)-Ib-cr and efﬂux pump genes among ESBL-positive K. pneumoniae clinical
isolates in Semmelweis University Clinics. This high frequency of PMQR genes
indicated that early detection and routine screening of ESBL-producing
K. pneumoniae and PMQR carriage seems necessary.
Earlier studies from Hungary demonstrated that diverse ﬁtness cost associ-
ated with resistance to FQs allowed the extensive dissemination of major
international clones of multiresistant K. pneumoniae in healthcare settings [33].
Other data showed that ciproﬂoxacin MIC values may play a role in dissemination
of major K. pneumoniae clones [34]. A study demonstrated the need for reduced
FQ consumption to prevent the spread of antimicrobial resistant microorganisms
among healthcare settings [35].
In addition, it is important to note carbapenemase production of Enter-
obacteriaceae. A study described that among 883 ESBL-positive Enterobac-
teriaceae, 1.6% were carbapenem resistant. For the optimal detection of
carbapenem-resistant microorganisms, molecular biological methods are recom-
mended. However, in resource-limited settings, a combination of phenotypic tests
can be applied in diagnostic labs [36].
The high prevalence of PMQR determinants should be considered as a
wake-up call, because of the latent ability of these genetic platforms, they may
recruit novel resistance mechanisms and promote the emergence of multidrug
resistant isolates.
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